Brief: Xintela Signs Agreement Worth SEK 3.6 Mln
Aug 30 (Reuters) - Xintela AB XINT.ST :
* SAID ON THURSDAY XINTELA SIGNS AGREEMENT WITH REGION
ÖSTERGÖTLAND FOR GMP PROCESS DEVELOPMENT OF CELL THERAPY FOR
BURN PATIENTS
* THE AGREEMENT IS WORTH SEK 3.6 MILLION
Source text for Workspace: urn:newsml:reuters.com:*:nMFN2v5pH6
Further company coverage: XINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Xintela AB
See all newsBrief: Xintela To Raise SEK 30 Mln Via Convertible Loan From Flerie Invest
Advisory: Alerts on Xintela's phase I/IIa XSTEM results withdrawn
Brief: Xintela Q1 2026 Loss Before Tax SEK 11.8 Mln
Brief: Xintela Study Finds XSTEM Treatment Safe, Well Tolerated
Brief: Xintela Gets U.S. Patent For Xstem Treatment Of Difficult-To-Heal Wounds, Skin Defects